Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Julienne K. Kirk & Clifford F. Gonzales. (2023) Preoperative considerations for patients with diabetes. Expert Review of Endocrinology & Metabolism 18:6, pages 503-512.
Read now
Read now
Aminu Mohammed, Victoria Awolola Gbonjubola, Neil Anthony Koorbanally & Md. Shahidul Islam. (2017) Inhibition of key enzymes linked to type 2 diabetes by compounds isolated from Aframomum melegueta fruit. Pharmaceutical Biology 55:1, pages 1010-1016.
Read now
Read now
Articles from other publishers (24)
Yue Zhang, Anthony Henry Harker, C.J. Luo, Maryam Parhizkar & Mohan Edirisinghe. (2022) Co-delivery of saxagliptin and dapagliflozin by electrosprayed trilayer poly (D, -lactide-co-glycolide) nanoparticles for controlled drug delivery. International Journal of Pharmaceutics 628, pages 122279.
Crossref
Crossref
Md. Tanvir Kabir, Jannatul Ferdous Mitu, Raushanara Akter, Muhammad Furqan Akhtar, Ammara Saleem, Ahmed Al-Harrasi, Saurabh Bhatia, Md. Sohanur Rahman, Fouad Damiri, Mohammed Berrada & Md. Habibur Rahman. (2022) Therapeutic potential of dopamine agonists in the treatment of type 2 diabetes mellitus. Environmental Science and Pollution Research 29:31, pages 46385-46404.
Crossref
Crossref
Amelia D. Dahlén, Giovanna Dashi, Ivan Maslov, Misty M. Attwood, Jörgen Jonsson, Vladimir Trukhan & Helgi B. Schiöth. (2022) Trends in Antidiabetic Drug Discovery: FDA Approved Drugs, New Drugs in Clinical Trials and Global Sales. Frontiers in Pharmacology 12.
Crossref
Crossref
Artur Rydosz. 2022. Diabetes Without Needles. Diabetes Without Needles
27
92
.
Hiroshi Maegawa, Kazuyuki Tobe, Ichiro Nakamura & Satoshi Uno. (2021) Real-world evidence for long-term safety and effectiveness of ipragliflozin in treatment-naïve versus non-naïve Japanese patients with type 2 diabetes mellitus: subgroup analysis of a 3-year post-marketing surveillance study (STELLA-LONG TERM). Diabetology International 12:4, pages 430-444.
Crossref
Crossref
Qilin Yang, Jiezhao Zheng, Weiyan Chen, Xiaohua Chen, Deliang Wen, Weixiao Chen, Xuming Xiong & Zhenhui Zhang. (2021) Association Between Preadmission Metformin Use and Outcomes in Intensive Care Unit Patients With Sepsis and Type 2 Diabetes: A Cohort Study. Frontiers in Medicine 8.
Crossref
Crossref
Daria Ja’arah, Mazhar Salim Al Zoubi, Gamal Abdelhady, Firas Rabi & Murtaza M Tambuwala. (2021) Role of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Hypoglycemia. Clinical Medicine Insights: Endocrinology and Diabetes 14, pages 117955142110516.
Crossref
Crossref
KyeongJin Kim, Wen-Hao Yang, Youn-Sang Jung & Jong-ho Cha. (2020) A new aspect of an old friend: the beneficial effect of metformin on anti-tumor immunity. BMB Reports 53:10, pages 512-520.
Crossref
Crossref
Yong Wang, Haiying Wang & Fengzhen Yang. (2020) Barbaloin Treatment Contributes to the Rebalance of Glucose and Lipid Homeostasis of Gestational Diabetes Mellitus Mice. Dose-Response 18:4, pages 155932582098491.
Crossref
Crossref
Emmanuel Ayobami Makinde, Nisaudah Radenahmad, Ademola Ezekiel Adekoya & Opeyemi Joshua Olatunji. (2020)
Tiliacora triandra
extract possesses antidiabetic effects in high fat diet/streptozotocin‐induced diabetes in rats
. Journal of Food Biochemistry 44:6.
Crossref
Crossref
Mala Dharmalingam, S. R. Aravind, Hemant Thacker, S. Paramesh, Brij Mohan, Manoj Chawla, Arthur Asirvatham, Ramesh Goyal, Jayashri Shembalkar, R. Balamurugan, Pradnya Kadam, Hansraj Alva, Rahul Kodgule, Monika Tandon, Sivakumar Vaidyanathan, Amol Pendse, Rajesh Gaikwad, Sagar Katare, Sachin Suryawanshi & Hanmant Barkate. (2020) Efficacy and Safety of Remogliflozin Etabonate, a New Sodium Glucose Co-Transporter-2 Inhibitor, in Patients with Type 2 Diabetes Mellitus: A 24-Week, Randomized, Double-Blind, Active-Controlled Trial. Drugs 80:6, pages 587-600.
Crossref
Crossref
Nadia Mazarakis, Kenneth Snibson, Paul V. Licciardi & Tom C. Karagiannis. (2020) The potential use of l-sulforaphane for the treatment of chronic inflammatory diseases: A review of the clinical evidence. Clinical Nutrition 39:3, pages 664-675.
Crossref
Crossref
Kohei Kaku, Koichi Kisanuki, Mari Shibata & Takashi Oohira. (2019) Benefit-Risk Assessment of Alogliptin for the Treatment of Type 2 Diabetes Mellitus. Drug Safety 42:11, pages 1311-1327.
Crossref
Crossref
E.A. Makinde, C. Ovatlarnporn, A.E. Adekoya, O.F. Nwabor & O.J. Olatunji. (2019) Antidiabetic, antioxidant and antimicrobial activity of the aerial part of Tiliacora triandra. South African Journal of Botany 125, pages 337-343.
Crossref
Crossref
S. Uysal, G. Zengin, M.F. Mahomoodally, M.A. Yilmaz & A. Aktumsek. (2019) Chemical profile, antioxidant properties and enzyme inhibitory effects of the root extracts of selected Potentilla species. South African Journal of Botany 120, pages 124-128.
Crossref
Crossref
Sengul Uysal, Asli Ugurlu, Gokhan Zengin, Mehmet Cengiz Baloglu, Yasemin Celik Altunoglu, Adriano Mollica, Luisa Custodio, Nuno R. Neng, José M.F. Nogueira & M. Fawzi Mahomoodally. (2018) Novel in vitro and in silico insights of the multi-biological activities and chemical composition of Bidens tripartita L.. Food and Chemical Toxicology 111, pages 525-536.
Crossref
Crossref
Morana Jaganjac, Shamma Almuraikhy, Fatima Al-Khelaifi, Mashael Al-Jaber, Moataz Bashah, Nayef A. Mazloum, Kamelija Zarkovic, Neven Zarkovic, Georg Waeg, Wael Kafienah & Mohamed A. Elrayess. (2017) Combined metformin and insulin treatment reverses metabolically impaired omental adipogenesis and accumulation of 4-hydroxynonenal in obese diabetic patients. Redox Biology 12, pages 483-490.
Crossref
Crossref
Fabrice Bonnet & André Scheen. (2017) Understanding and overcoming metformin gastrointestinal intolerance. Diabetes, Obesity and Metabolism 19:4, pages 473-481.
Crossref
Crossref
John J. Wallbillich, Srirama Josyula, Uksha Saini, Roman A. Zingarelli, Kalpana Deepa Priya Dorayappan, Maria K. Riley, Ross A. Wanner, David E. Cohn & Karuppaiyah Selvendiran. (2017) High Glucose-Mediated STAT3 Activation in Endometrial Cancer Is Inhibited by Metformin: Therapeutic Implications for Endometrial Cancer. PLOS ONE 12:1, pages e0170318.
Crossref
Crossref
Asghar Ghasemi, S. Khalifi & S. Jedi. (2014) Streptozotocin-nicotinamide-induced rat model of type 2 diabetes (review). Acta Physiologica Hungarica 101:4, pages 408-420.
Crossref
Crossref
Carole M. Nasrallah & Tamas L. Horvath. (2014) Mitochondrial dynamics in the central regulation of metabolism. Nature Reviews Endocrinology 10:11, pages 650-658.
Crossref
Crossref
D. Allan Butterfield, Fabio Di Domenico & Eugenio Barone. (2014) Elevated risk of type 2 diabetes for development of Alzheimer disease: A key role for oxidative stress in brain. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1842:9, pages 1693-1706.
Crossref
Crossref
Gerardo D. Anaya-Eugenio, Isabel Rivero-Cruz, José Rivera-Chávez & Rachel Mata. (2014) Hypoglycemic properties of some preparations and compounds from Artemisia ludoviciana Nutt. Journal of Ethnopharmacology 155:1, pages 416-425.
Crossref
Crossref
Pelbreton C. BalfourJr.Jr., Carlos J. Rodriguez & Keith C. Ferdinand. (2014) Blood Pressure and Cardiovascular Effects of New and Emerging Antidiabetic Agents. Current Hypertension Reports 16:8.
Crossref
Crossref